<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02186639</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-Nr. 2014-0088</org_study_id>
    <nct_id>NCT02186639</nct_id>
  </id_info>
  <brief_title>Breath Analysis in Chronic Obstructive Lung Disease (COPD)</brief_title>
  <official_title>Exhaled Breath Analysis in Patients With COPD by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To answer the question whether a disease specific profile of breath in patients with COPD can
      be detected by an untargeted metabolomic study using exhaled breath analysis by mass
      spectrometry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study comparing the volatile organic compounds (VOCs) in exhaled
      breath between COPD patients and matched control subjects (age, gender, smoking-state). 40
      COPD patients (20 non-frequent, 20 frequent exacerbators) and 40 matched controls will be
      examined by SESI-MS on the composition of exhaled breath for identification of COPD specific
      markers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COPD-specific mass spectrometric exhaled breath pattern</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
    <description>40 COPD patients (20 non-frequent and 20 frequent-exacerbators). No intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Subjects with no apparent lung disease and normal lung function testing. Matched for age, gender and smoking history (pack years).
No intervention.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited in primary, secondary and tertiary care clinics. Healthy
        controls will be recruited from a community sample.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed COPD GOLD stage I-IV, based on a post-bronchodilator spirometry (FEV1/FVC &lt;
             0.7) performed within the last 6 months

          -  age between 18 and 80 years at study entry

          -  healthy controls: normal spirometry

        Exclusion Criteria:

          -  COPD exacerbation within the last 6 weeks

          -  any lung disease other than COPD

          -  acute inflammatory disease (e.g. common cold) within the last 6 weeks

          -  acute or chronic hepatic disease

          -  renal failure or renal replacement therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malcolm Kohler, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Pulmonary Division</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Pulmonary Division</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2014</study_first_submitted>
  <study_first_submitted_qc>July 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2014</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exhaled breath</keyword>
  <keyword>volatile organic compounds (VOCs)</keyword>
  <keyword>SESI-MS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

